SUMMIT Study Shows Off Power Of Mass Cancer Screening
SUMMIT, the landmark study conducted within the UK focused on diagnosing lung cancer before it becomes untreatable, has demonstrated the practicality and cost effectiveness of mass CT screening.
You may also be interested in...
Allelica, a company specializing in diagnostics "software as a service," has obtained $1.75m in seed funding to bring genomic risk prediction to the forefront of patient care.
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.
Prescience Point Capital is trying to reshuffle the board of directors leading regenerative medicine company MiMedx, arguing the company’s current board has destroyed shareholder value. The company's tock is selling for about a third of its potential value, according to Prescience.